Sleep Disorders Linked to Chronic Liver Disease
A 2026 meta-analysis found a high prevalence of liver conditions among patients with sleep-disordered breathing.
Updated on Sept. 30, 2026 in Sleep Disorders
Live Poll
Should patients with chronic sleep apnea undergo routine screening for liver health?
A 2026 systematic review identified a strong association between sleep-disordered breathing and metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers found that nocturnal hypoxemia may serve as a more significant predictor of liver damage than the apnea-hypopnea index.
Why it matters
The study suggests that physicians should consider routine liver assessments for patients diagnosed with obstructive sleep apnea or other sleep-disordered breathing conditions. Understanding this link could lead to earlier detection and intervention for metabolic liver damage in at-risk individuals.
A systematic review of 8 studies found a 75.1% prevalence of MASLD among those with sleep-disordered breathing. Moderate-to-severe OSA showed a 3.48 odds ratio for association with advanced liver fibrosis.
The details
The analysis revealed that while continuous positive airway pressure (CPAP) therapy was linked to a mean reduction of 7.15 U/L in alanine aminotransferase and 3.38 U/L in aspartate aminotransferase, it did not significantly improve liver structure. Data from five studies further indicated a 13.9% pooled prevalence of liver fibrosis or fibrosis risk in the patient population.
Timeline
The systematic review and meta-analysis was published in 2026.
The Big Picture
This study expands the clinical diagnostic criteria for Metabolic Dysfunction-Associated Steatotic Liver Disease by incorporating sleep health as a critical risk factor for metabolic liver progression. It suggests that systemic metabolic health requires an integrated approach to airway and liver function.
Patients diagnosed with sleep apnea should discuss potential liver health monitoring with their primary care physician. While CPAP treatment helps reduce liver enzyme levels, it may not be sufficient on its own to resolve existing structural liver fibrosis.
The takeaway
Clinicians and patients should recognize that sleep-disordered breathing extends beyond respiratory concerns to include significant metabolic risks. Routine liver health screenings should be prioritized for individuals suffering from chronic sleep-disordered breathing.
Further reading
For additional context on the management of sleep conditions, explore our Sleep Disorders section.
More information
View the complete systematic review and meta-analysis for comprehensive methodology and findings.
Source note: This article includes information reported by Ajmc.
Live Poll
Should patients with chronic sleep apnea undergo routine screening for liver health?
